HLTHQ — Cue Health Share News
0.000.00%
Last trade - 00:00TechnologySpeculativeMicro Cap
- $0.00m
- -$39.49m
- $70.94m
Brief: Cue Health Reports First Quarter 2023 Financial Results
Brief: Cue Health Makes De Novo Submission To FDA For Full Clearance Of Its Cue® Rsv Molecular Test
Cue Health Inc expected to post a loss of 61 cents a share - Earnings Preview
Cue Health to further reduce workforce by about 30%, shares up
Brief: Cue Health Says On April 28 Announced That It Was Implementing A New Cost Reduction Plan
U.S. STOCKS ON THE MOVE-Cue Health, Charles Schwab, Semtech
Cue Health rises as FDA allows emergency use of mpox test
Brief: Cue Health Receives FDA Emergency Use Authorization For Molecular Mpox Test
U.S. RESEARCH ROUNDUP-Booking Holdings, FedEx, LivePerson
Brief: Cue Health Inc Files For Mixed Shelf Of Up To $250 Million – SEC Filing
Cue Health Inc reports results for the quarter ended in December - Earnings Summary
Brief: Cue Health expects Q1 revenue USD 20-25 million
Brief: Cue Health Reports Q4 And Full-Year 2022 Financial Results
Cue Health Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Cue Health Inc - Company Does Not Hold Any Deposits At Svb Or Have Any Other Direct Investments At Svb
Brief: Cue Health Inc - On January 5, 2023, Co Announced That It Was Implementing A New Cost Reduction Plan
Brief: Cue Health Announces Appointment Of Josh Ghaim, Ph.D. And Sachin Jain, M.D. To Its Board Of Directors
U.S. RESEARCH ROUNDUP-Coherent, Huntington Ingalls Industries, Spirit Aerosystems Holdings
Cue Health Inc reports results for the quarter ended in September - Earnings Summary